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Synthetic petroleum-based polymers and natural plant polymers have the disadvantage
of restricted sources, in addition to the non-biodegradability of the former ones. In
contrast, eco-sustainable microbial polysaccharides, of low-cost and standardized
production, represent an alternative to address this situation. With a strong global
market, they attracted worldwide attention because of their novel and unique
physico-chemical properties as well as varied industrial applications, and many of
them are promptly becoming economically competitive. Scleroglucan, a β-1,3-β-1,6-
glucan secreted by Sclerotium fungi, exhibits high potential for commercialization and
may show different branching frequency, side-chain length, and/or molecular weight
depending on the producing strain or culture conditions. Water-solubility, viscosifying
ability and wide stability over temperature, pH and salinity make scleroglucan useful
for different biotechnological (enhanced oil recovery, food additives, drug delivery,
cosmetic and pharmaceutical products, biocompatible materials, etc.), and biomedical
(immunoceutical, antitumor, etc.) applications. It can be copiously produced at
bioreactor scale under standardized conditions, where a high exopolysaccharide
concentration normally governs the process optimization. Operative and nutritional
conditions, as well as the incidence of scleroglucan downstream processing will be
discussed in this chapter. The relevance of using standardized inocula from selected
strains and experiences concerning the intricate scleroglucan scaling-up will be also
herein outlined.
Keywords: scleroglucan, fermentation, bioreactor, optimization, non-conventional substrates, downstream
processing
THE DISCOVERY OF A CHALLENGING POLYSACCHARIDE
Around 180-million-tons of polymers are produced per year, which play a relevant role in our
modern society. Petroleum-based polymers and polymers of plant origin have the disadvantage
of their limited resources in addition to the well-known environmental impact of the former
ones. In this context, microbial polysaccharides represent a valuable alternative, with the beneﬁt
of lower-cost, standardized and sustainable production, along with high quality. In addition,
exopolysaccharides (EPSs) frommicrobial sources usually exhibit shortened production times (e.g.,
in a matter of days), the possibility of using industrial wastes, no competition with production
lands, and their frequent ease of recovery. Production values in the microbial EPS ﬁeld can be so
varied as 0.0022–86.3 g/L (Donot et al., 2012).
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Among microbial polysaccharides, the general term
scleroglucan is commonly used to designate a class of EPSs
with similar structure, which are mainly -but not exclusively-
produced by ﬁlamentous fungi of the genus Sclerotium (Halleck,
1967). Upon complete hydrolysis, only D-glucose is released
from this water-soluble homopolysaccharide. The Pioneering
Research Division of the US Army Quartermaster Corps
Research and Engineering Centre provided, in Reese and
Mandels (1959), the ﬁrst insights into the scleroglucan structure
by enzymatic approaches. Thereafter, in Halleck (1967) patented
the scleroglucan basic structure as elucidated by means of
enzymatic hydrolysis. This patent also included information
about some producing strains, the production processes and
the methods of puriﬁcation thereof (Halleck, 1967). Based on
Halleck’s work, Pillsbury Co. (Minneapolis, MN, USA) began
scleroglucan commercialization under the name Polytran R©. Since
then, diﬀerent companies entered into the scleroglucan market
under diﬀerent trademarks (Clearogel, Polytetran, Polytran FS,
Sclerogum, and Actigum; Coviello et al., 2005).
SCLEROGLUCAN CHEMICAL
STRUCTURE AND CONFORMATIONAL
FEATURES
Scleroglucan is a high molecular weight (MW), non-ionic
branched glucan. It consists in a backbone of (1,3)-β-linked
D-glucopyranosyl residues bearing a single (1,6)-β-linked
D-glucopyranosyl unit every three sugar residues of the main
chain (Rinaudo and Vincendon, 1982; Fariña, 1997). The
structure of this repetitive unit determines a degree of branching
(DB) around 0.33 (Figure 1). Besides being a common feature
among most biologically active β-(1,3)-glucans (Rinaudo and
Vincendon, 1982; Bohn and BeMiller, 1995; Kim et al., 2000), this
high branching frequency would also be responsible of the great
water solubility of this polysaccharide. When dissolved in water
at room temperature and low concentrations of alkali, usually
below 0.15 M NaOH, it can be assumed that scleroglucan adopts
a highly ordered, rigid, triple helical tertiary structure (Figure 1).
Under this macromolecular conformation, protruding (1,6)-
β-glycosidic side branching prevents the intermolecular
approach by extensive H-bonding, which otherwise would lead
to aggregated forms and precipitation (Fariña et al., 2001, 2009;
Laroche and Michaud, 2007). Meanwhile, interstrand hydrogen
bonding at the center of the triplex stabilizes the macromolecular
structure (Atkins and Parker, 1968; Bluhm et al., 1982; Sletmoen
et al., 2009). However, at higher NaOH concentrations, where
drastic changes in viscosity are commonly observed, the triple-
strand helices probably undergo the ionization of hydroxyl
groups which thus disrupts hydrogen bonds and prompts the
subsequent polysaccharide denaturation (Fariña et al., 2001;
Viñarta et al., 2013a).
To deepen into the knowledge of this denaturation–
renaturation process, Virgili Alemán (2011) monitored, by
ﬂuorescence resonance energy transfer (FRET) spectroscopy, the
conformational changes of scleroglucan triplexes when exposed
to diﬀerent NaOH concentrations. This study revealed that
triple helix denaturation would take place by a partial opening
mechanism, with a degree of opening related to both the NaOH
concentration and the EPS conformational features (degree of
expansion) of the triplexes.
The length of polymer chain, and therefore the molecular
mass of scleroglucan, may diﬀer depending on the microbial
strain, fermentation process (culture media, fermentation time,
etc.) and the recovery method used, with an averageMW ranging
from 1.3–3.2 × 105 to 0.3–6.0 × 106 Da (Rodgers, 1973; Fariña
et al., 2001). Within this range, Sclerotium rolfsii ATCC 201126
scleroglucan exhibits an average MW of about 5.2 × 106 Da
for the triplex and 1.6–1.7 × 106 Da for the random coil, in
association to high intrinsic viscosities ([η] = 9510–9610 mL/g,
for the triplex in water; Fariña et al., 2001). With reference to the
degree of polymerization (DP), the reported values are variable
from 110 for Sclerotium glucanicum scleroglucan (Bielecki and
Galas, 1991), 800 for a commercial scleroglucan (Bluhm et al.,
1982), 500–1600 for related glucans (Sandford, 1979), 2400–2500
for S. rolfsii ATCC 201126 scleroglucan (Fariña et al., 2009) and
up to 5600 for another cited scleroglucan (Rice et al., 2004).
A tendency to adopt a highly ordered, triple-helical
conformation and semi-rigid structure in neutral aqueous
solution, in association to high DP and MW (∼5 × 106 Da)
values, may account for the marked viscosifying ability,
outstanding rheological behavior and the emerging scleroglucan
successful applications (Yanaki et al., 1981; Brigand, 1993; Falch
et al., 2000; Fariña et al., 2001; Viñarta et al., 2006, 2007; Giavasis,
2014).
A BRIEF PANE ON SCLEROGLUCAN
PROPERTIES AND APPLICATIONS
Scleroglucan exhibits a range of distinctive physico-chemical
properties that provide an advantage to itself over other
polysaccharides, especially for the development of certain
products and processes. Nevertheless, slight to great variations of
these properties may be seen depending on the producing strain,
the polymer production process and the downstream processing,
facts that might modify the MW, DP, DB, conformational
parameters, and/or the polymer purity grade, and so will
determine its ﬁnal potential applications. For instance, we
reported that low concentrations (e.g., 2 g/L) of pure (∼90–98%
EPS) S. rolfsiiATCC201126 scleroglucan in water are able to yield
highly viscous solutions with non-Newtonian, non-thixotropic
and pseudoplastic behavior (Fariña et al., 2001, 2009; Viñarta
et al., 2007).
Solutions of scleroglucan are notably stable over temperature
up to 100–120◦C, and within a broad range of pH (1–
13). Additionally, the EPS neutral nature allows keeping
pseudoplasticity even in the presence of a variety of salts, such
as NaCl, KCl, CaCl2, MgCl2, and MnCl2 (Fariña et al., 2001;
Viñarta et al., 2013a). In contrast, slightly reﬁned solutions
(2 g/L) of commercial scleroglucans and crude polymer isolates
from fermentation broths produce lower viscosity solutions
with a lesser ability to retain stable rheological features when
exposed to alkali, high temperatures, or salts (Wang and McNeil,
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FIGURE 1 | (A) β-(1,3)-β-(1,6) glucan structure exhibiting the (3:1) side branching ratio of scleroglucan (Martin et al., 2007). (B) Tridimensional conformation of
scleroglucan triplex. Projection perpendicular to the fiber axis (Crescenzi et al., 1988).
1996; Viñarta et al., 2007, 2013a). Diﬀerences depending on
the EPS purity grade were also found between Biopolymer
CS6 (60–70% scleroglucan) and Biopolymer CS11 (85–90%;
Survase et al., 2007a). Based on these and other outstanding
scleroglucan properties, a wide spectrum of biotechnological and
industrial applications has been proposed and evaluated up to
date (Table 1).
Scleroglucan as triplex exhibits the tendency to form thermo-
reversible gels at low temperatures (close to 7◦C), due to a weakly
interacting triple-helix cross-linking mechanism (Bluhm et al.,
1982; Biver et al., 1986). On the other hand, mimicking the
behavior of other closely related β-(1-3)-D-glucans, scleroglucan
triple helices can also be aﬀected by denaturing conditions (e.g.,
pH ≥ 13), where destabilization of the interstrand H-bonding
leads to the dissociation into single stranded random coils
(Deslandes et al., 1980; Norisuye et al., 1980; Bluhm et al., 1982;
Yanaki and Norisuye, 1983; Ensley et al., 1994). Denaturation of
triplexes may occur in alkaline solutions (≥0.25 M NaOH), in
dimethylsulfoxide (DMSO; water weight fraction, WH < 0.13),
or by increasing the temperature above the triplex melting
temperature (Tm ∼= 135◦C; Fariña et al., 2001; Sletmoen et al.,
2009; Viñarta et al., 2013a). Typically, denatured solutions show
much lower or nil viscosity as compared to the triplex-containing
solutions. Nevertheless, under certain conditions, if denatured
samples are taken to conditions that favor the restoration of
the triple helical structure, circular structures might be observed
by ultramicroscopy techniques among the “renatured triplexes”
(Stokke et al., 1991, 1993; Sletmoen et al., 2009).
With regard to the scleroglucan biological properties, it
was reported that its administration by diverse routes in rats
and dogs did not induce toxicity, tissue pathology, or blood
abnormalities. Neither eye nor skin irritation was detected in
pigs, rabbits, and humans. Furthermore, scleroglucan role as an
immune stimulant and a non-digestible dietary ﬁber for humans
has been reported (Rodgers, 1973; Rapp, 1989; Giavasis, 2014).
A wide range of physico-chemical, nutritional, and biological
properties have been extensively described in the literature, and
certainly are worth to mention. Relevant activities for health
involve hypocholesterolemic, hypoglycemic, health-promoting
eﬀects, antioxidant and anti-obesity properties, many of them
applicable for developing functional foods or nutraceuticals
(Giavasis, 2014). A general overview of relevant polymer features
and their actual or potential implications are depicted in Table 1.
REVIEWING THE KNOWLEDGE AND
ADVANCES ON SCLEROGLUCAN
PRODUCTION
To date, all scleroglucan production processes take place with
a selected producing strain and under submerged aerobic
conditions. This process is generally carried out in stirred-tank
reactors using a sterile medium under aseptic management of
the culture. Scleroglucan synthesis proceeds along with mycelial
growth, so that the culture broth develops with time a gel-like
consistency (Rodgers, 1973). A sharp drop in pH (∼2–2.5) is
normally observed during the ﬁrst 12–24 h of cultivation, mainly
due to the accumulation of oxalic acid (Maxwell and Bateman,
1968; Fariña et al., 1998; Lee, 1998).
As aforementioned, changes in culture medium composition,
process parameters or even the downstream processing may lead
to dissimilar scleroglucan recovery and quality, with eventual
variations in its chemical, physical, and/or biological properties.
Therefore, in order to obtain high yields of a consistent polymer,
it becomes essential to standardize a large-scale production
process with a given strain under controlled conditions (Fariña
et al., 1998; Survase et al., 2007a; Fazenda et al., 2008; Seviour
et al., 2011a). A quite relevant step consists in selecting an
appropriate producing strain, whose preservation procedure
should be assessed and standardized, and its production ability
must be monitored over time (Fariña et al., 1996; Survase et al.,
2006; Schmid, 2008).
The nutritional requirements and culture conditions are
commonly evaluated at minor scale (i.e., shake ﬂasks) at the
beginning of optimization, in order to maximize scleroglucan
production and simultaneously reduce the accumulation of
unwanted by-products, such as oxalic acid (Fariña et al., 1998;
Schilling et al., 2000; Valdez, 2013). Following these essential
studies, the scaling-up to bioreactor becomes a critical but
diﬃcult step, and this issue will be discussed later.
From our research on scleroglucan production during the
last two decades, S. rolfsii ATCC 201126 (Figure 2) became
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TABLE 1 | Summary of the main scleroglucan applications, according to its refined grade and its physico-chemical, biological, and biotechnological
properties.
Scleroglucan source Highlighted scleroglucan properties Proposed applications Reference
Actigum CS-11∗
(formerly known as
Polytran R© from Ceca
S.A., France)
• Water solubility
• Viscosifying activity
• Salts tolerance
Scleroglucan aqueous fluid, used for
petroleum recovery
Doster et al., 1984a,b
Sclerotium rolfsii ATCC
15206
Actigum CS-11∗ and
Actigum CS6∗∗ , by
Sanofi Bio Industries,
France
• Thickening power
• High carrying capacity and lubricating power
Scleroglucan gels for enhanced oil
recovery (EOR)
Holzwarth, 1984;
Donche et al., 1994;
Pirri et al., 1996
Actigum CS-11∗ and
CS-6∗∗ , by Sanofi Bio
Industries, France
• Viscosifying ability
• Rheological stability vs. temperature, salinity,
and pH
Viscosity control of a bituminous binder
for road repair and construction, soil
stabilization, and sealing in civil
engineering
Chaverot et al., 2001
Polytran R© , by Pillsbury
Company, USA
• Stimulation of murine macrophage activity
• Increase in murine macrophage tumor cytotoxicity
• Enhancement of murine bone marrow proliferation
• Increase in survival of carcinoma-challenged mice
• Increase in mice resistance against pathogenic bacteria
and virus, w/o toxicity or hepatomegaly
Immune stimulating Pretus et al., 1991
Not specified • Apt matrix for controlled drug delivery
• Drug protection at gastric level
• Bioadhesive properties
• Biodegradability
Edible films and tablets for
nutraceuticals and pharmaceuticals
Capsule granulates for controlled
release of active substances
Lovrecich and Riccioni,
1991, 1993
Actigum CS11∗ , by
Mero Rousselot - Satia,
France
• Biocompatibility
• Thermal and chemical stability
Grassi et al., 1996;
Coviello et al., 1999
Not specified • Antitumour, antiviral, and antibacterial activity (native or
derivatized)
Drugs, vaccines, and
immuno-potentiators (combinable with
chemotherapy)
Jong and Donovick,
1989; Giavasis, 2014
Scleroglucan, by Sanofi
Bio Industries, France
• Hypocholesterolemic, hypolipidemic, and hypoglycemic Nutraceuticals Mastromarino et al.,
1997
Scleroglucan purified
from fermentation
broth, provided by
Statoil/Norferm
• Stabilizer-texturizer at low pH and high temperature
• Edible-film forming properties
Functional foods
Low-calorie foods (since non-digestible)
Falch et al., 2000
Actigum CS6∗∗ and
CS11∗ , by Sanofi Bio
Industries, France
Vaussard et al., 1997
Actigum CS-11∗, by
Sanofi Bio Industries,
France
Amigel, by Alban Muller
International
• Homogeneity and thickening enhancer
• Softness developer
Component for washing keratinous
materials (e.g., shampoo, shower gel,
conditioner)
Dubief, 1996; Dubief
and Cauwet, 2000
Actigum CS-11∗, by
Satia, France
• Remains elastic at saliva viscosity (1.5–3 mPa.s), at a
physiological pH (5–9), and at physiological ionic strength
(15–80 mM)
Saliva substitution agent
Artificial tear water
Mouth rinse
Toothpaste
Van Nieuw Amerongen
et al., 1999
Actigum CS-11∗ and
CS-6∗∗ , by Sanofi Bio
Industries, France
• Viscosifying agent of polyol base solvents
• Long term stability at high temperatures and against
metal ion contaminants
Rheological modifier for thermal
insulation fluids
Skaggs and Swazey,
1999
S. rolfsii ATCC 15205 • Forms flexible, insoluble in water films when dried, but
swell readily
• Dispersing agent
• Smoothing agent
• Lubricating agent
• Emulsifier or co-emulsifier agent
• Improvement of fixing of dyes or UV-absorbers in
shampoo/conditioners
• Skin anti-inflammatory effect
Useful as active and/or excipient
ingredient in cosmetic formulations
(shampoo, conditioner, after-sun
preparations, skin care compositions)
and ophthalmological preparations
Maier et al., 2000, 2002
(Continued)
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TABLE 1 | Continued
Scleroglucan source Highlighted scleroglucan properties Proposed applications Reference
Not specified • Compatible thickening agent Component of a cosmetic mixture for
the oxidation tinting of keratin fibers
Lang and Cotteret,
2003
BIOVIS, by SKW,
Germany
• Suspending agent Formulation of an aqueous storable
cement used for cementing an area of a
borehole
Fanguy et al., 2006
S. rolfsii ATCC 201126 • Retrogradation preserving agent in cooked starch
pastes
• Synergic rheological improvement of starch-based
pastes (in water and milk)
Food stabilizer Viñarta et al., 2006
• Gel and film forming properties
• Particulate suspending properties
• Emulsifying activity
Drug delivery
Paper, painting, ceramic, cosmetic,
food and pharmaceutical industries
Bioremediation, agriculture, and
detergents
Viñarta et al., 2007
Not specified • Gelling and viscosifying properties
• Resistance to degradation, even at high temperatures
and after 500 days in seawater
Industrial and oil field operations where
acidizing procedures are applied
Welton et al., 2009a,b
Not specified • High flocculant capacity
• Fast settling rate
Addition to liquor of a Bayer process
fluid stream to improve the recovery of
alumina trihydrate
Chester et al., 2012a,b,
2013
∗Biopolymer CS-11 is a refined product and has a content of 85–90% polysaccharide.
∗∗Biopolymer CS-6 contains 60–75% scleroglucan.
FIGURE 2 | Microscopic (40×) observation of Sclerotium rolfsii ATCC
201126 mycelium after growth for 3 days at 30◦C in liquid PM20 (with
20 g/L sucrose, Fariña et al., 1998). Mycelium was disaggregated in 10%
w/v KOH.
the selected strain to obtain vast amounts of EPS. This usually
involved batch processes at diﬀerent working scales and/or with
varying fermentation strategies. This strain was isolated in the
ﬁeld as a phytopathogen from rotten red pepper. Based on our
screening, it was later deposited and cataloged in the ATCC
because of its marked ability to excrete biopolymer. There are
several aspects that must be considered in order to achieve
stable and maximum EPS productivity levels, many of them
which are shared in commonwith other microbial polysaccharide
production processes, and these will be herein revisited.
Strain Preservation
Although it may seem a minor issue, an adequate strain
preservation technique is undoubtedly recognized as a crucial
strategy in order to assure long-term viability as well as
the maintenance of fungal properties (Smith, 1988). In the
ﬁrst reports, scleroglucan-producing strain conservation was
performed by monthly transfers either on PDA or PDY slants
(Christias and Lockwood, 1973; Griﬃth and Compere, 1978;
Punja et al., 1982; Pilz et al., 1991). While this is a quite common
methodology, an alternatively described technique consists in the
preservation of mycelium in sterile distilled water (also known as
Castellani’s method; American Type Culture Collection, 1982).
These above and other methods were tested with diﬀerent
S. rolfsii strains isolated from nature (Fariña et al., 1996). Early
reports revealed that periodic sub-culturing on diﬀerent culture
media, followed by preservation at low temperature (4–7◦C),may
lead to a lack of viability and a critical decrease in scleroglucan
synthesizing capacity. Conversely, preservation as ‘sclerotia’ (the
resistance structures of the non-sporogenic S. rolfsii) in sterile
distilled water at 4◦C or even at room temperature (Figure 3),
allowed the retention of the glucanogenic ability at similar and
even higher levels than those observed for the abovementioned
methods, and even after years of preservation (Fariña et al.,
1996).
Inoculum Standardization
The success of scleroglucan production at bioreactor scale
also closely depends on the inoculum proportion and its
quality, which must be standardized (van Wollingen and
Seviour, 1986). It is known that the preparation of a standard
inoculum is usually problematic since the genus Sclerotium
does not produce spores, and because of the non-homogeneous
nature of mycelial suspensions. However, Sclerotium genus has
the ability of forming resistance structures called sclerotia,
which can be thereafter used for strain activation and inocula
preparation (Fariña et al., 1996; Survase et al., 2006). It has been
demonstrated that activation of water-stored sclerotia followed
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FIGURE 3 | Inocula preparation starting from sclerotia of S. rolfsii ATCC 201126. Sequence order:−→ (A) Sclerotia preserved in sterile distilled water −→(B)
Sclerotia germinated in Czapek malt agar −→(C) Sub-culturing in PM20 agar −→(D) Cultivation in PM20 liquid medium, at 220 rpm and 30◦C (Fariña et al., 1998).
by sub-culturing in liquid production medium (PM) allows the
proper preparation of relatively homogeneous suspensions for
inoculation (Figure 3), being possible to achieve scleroglucan
concentrations similar to those obtained with the strain
periodically activated (Fariña et al., 1996).
Another approach that greatly contributes to the preparation
of homogeneous inocula is the inclusion of a homogenization
step of mycelium-covered agar plugs, suspended in the
appropriate volume of culture medium. Standardized
proportions should then be used to assure reproducibility,
and the inoculum preparation can be safely performed with the
aid of a hand blender at controlled speed and for a given time,
under aseptic conditions (Fariña et al., 1998).
Cultivation Conditions
As for any other microbial process, scleroglucan production
requires some speciﬁc culture conditions which become critical
in order to achieve maximum productivity. These not only
involve nutritional requirements of the producing strain
but also operative conditions such as pH, temperature,
aeration, agitation, foam control and inoculum size, among
the most representative ones. For scleroglucan production
with S. rolfsii ATCC 201126, many of these conditions were
ﬁrst experimentally adjusted at ﬂask scale and then scaled-
up to bioreactor. Additionally, other groups working on
scleroglucan production have also evaluated most of these
parameters and showed agreement or not with our ﬁndings
with S. rolfsii ATCC 201126. These results will be subsequently
discussed.
Nutritional Requirements
Several reports state that broth concentrations of fungal EPSs
can be both aﬀected by the nature of carbon and nitrogen
sources, as well as by their initial concentration in culture broth
(Deshpande et al., 1992; Seviour et al., 2011b). It was also
described that highest amounts of biomass do not always lead
to optimal EPS production (Giavasis et al., 2005). In the case of
S. rolfsii ATCC 201126, as also found for other scleroglucans,
a high carbon to nitrogen ratio in culture medium would
be required to enhance EPS biosynthesis (Fariña et al., 1998;
Survase et al., 2007a). Additionally, concerning the nature of
nutritional sources, higher polymer concentrations would be
associated to the preferential use of sucrose as C-source and
NaNO3 as N-source. On the other hand, N-sources such as
(NH4)2SO4 and other NH3-based N-sources led to a signiﬁcant
decline in scleroglucan production, a fact likely related to a
negative metabolic regulation on the EPS biosynthetic machinery
by ammonium (Fariña et al., 1998, 1999). Similar ﬁndings
were observed for the EPS formation by Phoma herbarum
CCFEE 5080 (Selbmann et al., 2002b). As also described for
pullulan production (by Aureobasidium pullulans ATCC 9348),
the initiation of scleroglucan production by S. rolfsii ATCC
201126 did not coincide with nitrate exhaustion (Campbell
et al., 2003). In addition, carbohydrates other than sucrose
and glucose, or eventually non-conventional substrates, could
alternatively be used as C-sources for scleroglucan production
(Wang and McNeil, 1996; Selbmann et al., 2002a; Survase
et al., 2007b; Fosmer et al., 2010; Schmid et al., 2011; Valdez,
2013).
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Among culture medium characteristics, the C-source
concentration has normally exhibited a remarkable inﬂuence
on scleroglucan production (Fariña et al., 1998; Survase et al.,
2006). As emphasized above, a high C:N ratio usually favors
EPS production, and diﬀerent reasons were speculated for this
observation. One rational explanation would be the preferential
use of the C-source to produce a carbonaceous product
(polysaccharide) with lower osmotic eﬀects than the original
sugar substrate (sucrose), which would be available for growth
under future starvation conditions (Nelson et al., 2008). On the
other hand, an increase in scleroglucan production growing
under high-osmotic pressure conditions (e.g., 150 g/L sucrose)
could reasonably be part of an osmoregulation mechanism
(Fariña et al., 1998), as discussed below (see Eﬀect of Other
Factors). Scleroglucan production has been mentioned to occur
in parallel with cell rescue processes and alternative energy-
generating pathways, which may explain the EPS overproduction
as a mechanism for survival under anoxic or other stressing
conditions (Schmid et al., 2011).
In the case of S. rolfsii ATCC 201126, a 7.5-times increase
in carbon concentration as compared to the basal medium
(150 g/L vs. 20 g/L of sucrose, respectively), led to a ﬁvefold
increase in EPS concentration after 72 h of cultivation at shake-
ﬂask scale, with a similar behavior at fermenter scale (Fariña
et al., 1998, 2001). The detection of glucanases (β-1,3-glucanase,
β-1,6-glucanase, and β-glucosidase) under C-source limiting
conditions along with the ability to degrade scleroglucan was
early reported for S. glucanicum and S. rolfsii (Rapp, 1989;
Martin et al., 2007). In culture broths of S. rolfsii ATCC 201126,
reduced extracellular β-glucanase activity could be detected
at the end of cultivation with low sucrose concentrations
(e.g., 20 g/L sucrose for inoculum preparation). However, after
transferring the culture to the fermenter with a high-sucrose
PM (MOPT with 150 g/L), glucanases became undetectable.
The measured high residual sucrose concentrations, even at
the end of cultivation in MOPT (ca. 80–100 g/L), may repress
β-glucanase activity (Rau, 2004). Nevertheless, high titers of EPS
would be more likely related to an osmotically induced β-glucan
synthesis than to this glucanase catabolic repression (Fariña et al.,
1998, 2009; see Eﬀect of Other Factors). In addition, previous
reports on fungal glucan synthetase activity demonstrated that
the concentration of sucrose proved to be crucial for enzyme
stability at 30◦C (Leal et al., 1984; Finkelman and Vardanis,
1986).
Culture media with concentrations of glucose or sucrose
(30–35 g/L) lower than that one (150 g/L) being optimal for
S. rolfsii ATCC 201126 have been reported by diﬀerent authors,
with a maximum production of 8.5–10 g EPS/L (Wang and
McNeil, 1995d; Schilling et al., 2000). Nevertheless, the C-source
requirements seem to be strain-speciﬁc. In this sense, it has been
found for example that growth of S. glucanicum is completely
inhibited by sucrose concentrations above 45 g/L, which further
limits the scleroglucan production (Wang and McNeil, 1994).
On the other hand, similar to the eﬀects of high sucrose
concentrations in S. rolfsii ATCC 201126 (Fariña et al., 1998),
Survase et al. (2006) reported a maximum production of 16.5 g
EPS/L with a sucrose concentration of 80 g/L.
Other components of culture medium exhibited lesser
inﬂuence on scleroglucan production. In S. rolfsii ATCC 201126,
a change in phosphate concentration from 1.3 to 2 g/L led
to higher scleroglucan concentrations. Meanwhile, additional
constituents such as L-threonine and ascorbic acid signiﬁcantly
decreased scleroglucan production (Fariña et al., 1998). With
regard to nitrogen and phosphate sources, Taurhesia and
McNeil (1994a) found that higher titers of scleroglucan from
S. glucanicum were produced in a P-limited medium (18.9 g/L of
scleroglucan) than in a N-limited medium (11.4 g/L EPS). High
scleroglucan concentrations have also been commonly supported
by the presence of yeast extract and casein hydrolysates in culture
medium (Taurhesia and McNeil, 1994a).
To conclude, with regard to the scleroglucan production by
S. rolfsii, there seems to be much agreement in the culture
medium composition over the latest years, using optimized
culture medium formulations similar to MOPT, which contain
a high C:N ratio with sucrose as C-source (e.g., 150 g/L),
NaNO3 as N-source (in the order of 2.25 g/L), K2HPO4·3H2O
as P-source (∼2 g/L) and other minor components (in
g/L): KCl, 0.5; MgSO4·7H2O, 0.5; yeast extract, 1; citric
acid·H2O, 0.7; FeSO4·7H2O, 0.05 (initial pH adjusted to 4.5).
Cultivation of S. rolfsii ATCC 201126 at eight L-fermenter
scale by using this culture medium led to the highest
EPS production kinetic parameters (i.e., 26 g scleroglucan/L,
theoretical yield factor, Yp/c = 0.68 and volumetric productivity,
Pr = 0.542 g/L·h) at 48 h of fermentation (Fariña et al.,
1998).
Culture Conditions
The control and maintenance (or modulation) of operative
parameters becomes fundamental for a process optimization.
Some typical aspects for the particular case of scleroglucan
production will be discussed below. Along the scleroglucan
research history, many researchers and engineers have ventured
diﬀerent alternatives in a continuous eﬀort to improve EPS
production and puriﬁcation, and some of these will be herein
revisited.
Eﬀect of temperature
This parameter typically aﬀects both culture growth and
polysaccharide production. However, it has been reported that
in batch cultures, maximum EPS biosynthesis is achieved
at temperatures somewhat lower than the one for optimal
growth rate. When the organism growth rate is decreased
by reducing cultivation temperature, this may increase the
availability of isoprenoid lipid carrier for non-growth functions,
thus stimulating polysaccharide production (Wang and McNeil,
1996; Fosmer and Gibbons, 2011). Optimal biomass production
usually occurs at temperatures above 28◦C, while “optimum”
temperature for scleroglucan formation was found to be ∼28◦C
(Giavasis et al., 2005). Instead, below 28◦C, by-product (oxalic
acid) formation is gradually increased, so that at 20◦C acid
production may exceed biomass and EPS biosynthesis (Wang
and McNeil, 1995b). In the case of S. rolfsii ATCC 201126, the
production process is commonly carried out at 30◦C, obtaining
optimal EPS yields.
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Eﬀect of pH
This factor frequently inﬂuences the microorganism physiology
by aﬀecting both nutrient solubility and uptake, enzyme
activity, cell membrane morphology, by-product formation,
redox reactions, etc. (Giavasis et al., 2005). As described for
temperature, the appropriate pH for maximum polysaccharide
production can diﬀer from that for optimal growth. Kang and
Cottrell (1979), pointed out that the optimum pH for fungal
polysaccharide synthesis usually lies between 4.0 and 5.5.
First studies of pH eﬀects on scleroglucan production by
S. rolfsiiATCC 201126 were performed at shake ﬂask scale where,
after initial adjustment, pH was left uncontrolled. Comparison
of such results to those obtained in stirred-tank reactors is
not very diﬀerent, as most of the cultivations up to date
gave the best EPS values when pH was not ﬁxed to a given
set-point. It naturally reaches values of 2–2.5 at around 18–
24 h of fermentation with a slow and slight increase afterward
(Fariña, 1997; Fariña et al., 1998; Valdez, 2013). However, other
authors recommended the control of pH during scleroglucan
fermentation with S. glucanicum NRRL 3006 in order to achieve
higher polysaccharide titers (Wang and McNeil, 1995c). As the
automatic pH control implies extra costs and further handling
of the batch, this aspect will require a proper examination
depending on the species and/or the strain to be employed.
Eﬀect of dissolved oxygen (DO)
For aerobic organisms, particularly for fungi, oxygen plays a
vital role in many aspects of cellular metabolism. Changes
in dissolved oxygen often impact respiration rate, enzymatic
synthesis and activity, formation of metabolic products, etc.
(Forage et al., 1985). Rau et al. (1992) investigated the eﬀect of
DO on polymer biosynthesis by S. glucanicum. They reported
that a high oxygen supply resulted in increased cell growth rate
along with decreased scleroglucan production. In contrast, when
oxygen partial pressure in the liquid phase was almost reduced
to zero, the fungal response was a limited growth but the speciﬁc
stimulation of scleroglucan formation (Rau et al., 1992; Schilling
et al., 1999). Wang and McNeil (1995a) also suggested that, when
oxygen becomes limiting, growth undergoes a severe restriction
for the C usage, which in turns can be derived toward diﬀerent
metabolic activities such as polymer and/or oxalate production.
The eﬀect of limiting DO tension on the stimulation of
EPS production may be diﬃcult to understand; biopolymer
synthesis is an energy-demanding process and the generation
rate of energy in aerobic microorganisms always relates to
the oxygen supply. A reduction in culture DO, however, may
disturb fungal morphology, broth rheology or C assimilation, in
a favorable way for EPS biosynthesis (Olsvik and Kristiansen,
1994). Nevertheless, since EPS production has been found to start
before the DO levels reach limiting values, it becomes unlikely
that oxygen limitation triggers scleroglucan biosynthesis by itself
(Wang and McNeil, 1995a).
A previous report suggested that at high respiration rates
(high DO tension) more carbon would be converted into carbon
dioxide, thus leaving less available C-source for scleroglucan
production (Sutherland, 1977). Reaﬃrming this assumption,
Wang and McNeil proposed that low DO levels would lead
to restricted Sclerotium fungal growth (which is an aerobic
process) and consequently, more C-source could be driven
to scleroglucan biosynthesis. This is in agreement with the
statement that EPS production and cell growth are alternative
fates of the C-source. Therefore, it sounds very realistic the
rationale that, under certain conditions, the improved availability
of C is governing polysaccharide production (Wang and McNeil,
1995a). Moreover, low DO levels might decrease by-product
(oxalate) formation by repressing the synthetic enzyme glycolate
oxidase (Schilling et al., 2000), thus reducing the diversiﬁcation
of the C-source to undesirable products, and simultaneously
favoring the C-ﬂow toward β-glucan production.
Eﬀect of aeration and agitation rates
Optimizing aeration and agitation rates represents a critical
tool to control cell growth and scleroglucan production. These
parameters are related to an adequate culture mixing and the
suﬃcient mass and heat transfer rate, which can therefore
increase the transference of nutrients and oxygen from liquid
medium to the cells, and also modulate the rate of metabolite
release from cells to the surroundings, this latter including
biopolymers, by-products, and carbon dioxide (Giavasis et al.,
2005).
As aforementioned, EPS production is characterized by the
development of a very viscous culture broth that commonly
exhibits Non-Newtonian, pseudoplastic rheological behavior,
emphasized by the production of high biomass concentrations.
Furthermore, at moderate to low stirring rates, the fungus
forms mycelial pellets. These both phenomena result in the
development of a very heterogeneous culture, where nutrient
and oxygen transfer into the pellets, as well as metabolites and
toxic products release, become very limited or even nil (Forage
et al., 1985; Brown et al., 1987). Under these conditions, the shear
rate within the bioreactor varies extraordinarily, from the highest
value close to the impeller to the lowest one next to the vessel wall,
even in lab-scale stirred-tank reactors.
Fungal morphology in submerged cultures (pelleted vs.
dispersed ﬁlamentous growth) is aﬀected by a variety of cultural
parameters like inoculum strength, medium composition,
fermenter conﬁguration (see below) and particularly, agitation
rates (Papagianni, 2004; Fazenda et al., 2008). It was early
suggested that a pelleted fungal morphology in Sclerotium sp.
may produce higher β-glucan yields than diﬀuse mycelial cultures
(Gibbs et al., 2000; Papagianni, 2004; Wucherpfennig et al., 2010;
Schmid et al., 2011; Seviour et al., 2011a). Systematic studies
on the relationship between aeration rate, mycelial morphology
and EPS production were previously performed in Cordyceps
militaris, ﬁnding that DO starvation at low airﬂow levels led
to pellet autolysis and looser mycelial clumps. However, high
aeration rates were neither beneﬁcial. Intermediate values (2
vvm) led to compact mycelial pellets which resulted optimal for
cell growth and EPS production (Park et al., 2002). In the case
of S. rolfsii ATCC 201126, frequently working at 0.5 vvm and
400 rpm at fermenter scale, loose lenticular pellets are frequently
associated to an optimal scleroglucan production (Valdez, 2013).
In stirred tank reactors (STRs), the average shear rate in the
impeller zone is known to be a function of the impeller diameter
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and the impeller tip velocity. In pneumatic contactors such as
bubble column and air-lift reactors (ALRs), it depends on the
superﬁcial gas velocity (Forage et al., 1985; Wecker and Onken,
1991). Bulk mixing may be improved by either increasing the
impeller speed, increasing the gas velocity or altering the design
of fermenter and/or impellers (Wang and McNeil, 1996).
A critical balance should be maintained concerning stirring
rates, since scleroglucan would not be released from cell walls
at sub-optimal shear stress. Low shear stress has been linked
to the release of very low MW scleroglucan, whereas large
biopolymer molecules remained adhered to mycelial walls (Rau
et al., 1992). Poor bulk mixing may also add problems in terms
of process monitoring and control (Wang and McNeil, 1996).
However, very high stirring rates can usually lead to increased
damage of hyphal cells along with the degradation of biopolymer
macromolecular structure and the consequent reduction in broth
viscosity (Nielsen, 1992; Rau et al., 1992).
Similarly, Schilling et al. (1999) conﬁrmed that under high
stirring rates, the produced scleroglucan showed a low MW
as compared with that obtained after moderate agitation.
A combination of moderate agitation plus high aeration rate
allowed them to attain a maximum-MW scleroglucan. Although
good agitation may be essential for mixing, if surpassed, it
may adversely aﬀect culture viability or physiology or even
the EPS quality. Aeration, on the other hand, contributes to
good mixing in a milder manner with no disturbance of the
culture or polysaccharide molecular size (Giavasis et al., 2005).
Additionally, foam control at high agitation rates requires special
care since while some antifoams may considerably enhance EPS
production in certain fungi, others (e.g., some vegetable oils) are
known to be inhibitory (Stasinopoulos and Seviour, 1990; Fariña
et al., 1998; Yang et al., 2000; Hsieh et al., 2006).
There is limited literature concerning the production of
scleroglucan under diﬀerent airﬂow and stirring rates. Rau et al.
(1992) carried out batch cultivations with S. glucanicum CBS
52071 at diﬀerent airﬂow rates using draft-tube propeller systems
at a constant shear rate of 600 rpm. They reported that high
airﬂow rates, in the order of 0.3 m3/h, were associated to larger
growth rates and decreased scleroglucan formation.
Eﬀect of other factors
Some additional eﬀectors have been tested in order to increase
scleroglucan biosynthesis. Among these, it is worth to mention
the positive inﬂuence of high-osmotic-pressure conditions on
scleroglucan biosynthesis. For instance, in S. rolfsiiATCC201126,
the inﬂuence of high osmolarity on scleroglucan production was
partially evidenced by means of complementing the osmotic
eﬀects of culture media containing either 50 or 75 g/L-sucrose
with additional NaCl or KCl, in order to mimic the 150 g/L-
sucrose osmotic pressure (Fariña et al., 1998). Normally, in media
with 150 g/L sucrose as C-source (e.g., MOPT medium), where
EPS reaches the highest values, much of the sugar remains at the
end of the batch. This ﬁnding was already associated to an EPS
protective role and its increased production under high osmotic
pressure environments, where scleroglucan might be part of an
osmoregulation mechanism (Seviour et al., 1992; Fariña et al.,
1998; Schmid et al., 2010).
In natural environments, EPS formation has been linked
to substrate adhesion (e.g., bioﬁlm formation) or desiccation
prevention, among other roles (Donot et al., 2012). The
production of EPSs has been also described as an adaptation
strategy for microbial survival under stressing conditions such
as freezing. Ice crystal formation, osmotic pressure variations,
and water availability are factors normally related to cell stress
during freezing. This would agree with the current use of
polysaccharides (e.g., alginate) in cryopreservation techniques
and would explain the protective properties of EPSs in Antarctic
microbes to overcome lethal eﬀects of freeze-thaw cycles, which
are harsher than a continuously frozen environment (Selbmann
et al., 2002b).
As it was noted in a previous report (Fariña et al., 1996),
S. rolfsii ATCC 201126 was shown to be relatively halotolerant.
Although osmosity exhibited a signiﬁcant inﬂuence on β-glucan
production, the highest EPS values reached with 150 g/L sucrose
could not be equaled just by increasing culture medium osmotic
pressure by means of salts addition. The osmotically active salts
added to the medium did showed to increase EPS production
but, the normal scleroglucan concentration obtained in 150-
g/L-sucrose culture medium (MOPT) could not be achieved,
probably because of the high ionic strength exerted by the
NaCl or KCl surplus (Fariña et al., 1998). Similar evidences
were found while examining the eﬀects of osmotic pressure on
the erythritol production by Trigonopsis variabilis (Kim et al.,
1997).
Instead of salts, other non-metabolizable water activity (aw)
adjusters like polyethylene glycol (PEG) 200 have been already
cited in the literature, for example to study the osmotically
modiﬁed enzymatic production in Aspergillus niger (Taragano
et al., 1997) or to relate water activity depletion and the
stimulation of EPS production inGanoderma lucidum (Papinutti,
2010). In the latter case, and similarly to S. rolfsii ATCC
201126, an incomplete utilization of reducing sugars was found
at high malt extract concentrations, suggesting a high C-source
concentration as a positive eﬀector for EPS production by
decreasing water activity (Papinutti, 2010). Likewise, high solute
concentrations in culture medium have been related to a reduced
oxygen solubility and diﬀusion coeﬃcient (Büchs, 2001), which
may also stimulate EPS biosynthesis.
On the other hand, supplementation with sunﬂower oil
and ascorbic acid, and particularly with L-threonine, led to
a diminished EPS production in S. rolfsii ATCC 201126
(Fariña et al., 1998). Although some proteomic approaches
already described the activation of heat-shock proteins and the
increased expression of ATP citrate lyase (decreased TCA cycle
activity) with increased EPS production by Pleurotus tuber-
regium when stimulated by Tween 80 (Zhang et al., 2012), this
supplementation to culture medium did not exerted stimulation
toward EPS production in S. rolfsii ATCC 201126 (Fariña
et al., 1998). In addition to the inﬂuence of culture medium
composition, and with regard to external factors other than those
already discussed, some authors also found that white or blue
light facilitated glucan formation in S. rolfsii (Miller and Liberta,
1976), but no further information is currently available on this
aspect.
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In the particular case of S. rolfsiiATCC 201126, several studies
performed at shake-ﬂask scale during the last decades allowed to
establish optimal conditions for scleroglucan production (Fariña
et al., 1996, 1998). Subsequently, when scaling-up to bioreactor
scale, stirred-tank reactors were used under the following
operative conditions: airﬂow rate, 0.5 vvm; stirrer speed, 400 rpm;
temperature, 30◦C and initial pH 4.5 (uncontrolled throughout
the fermentation process). These conditions allowed to achieve
a 1.5-fold increase in volumetric productivity (Pr, from 0.365
up to 0.542 g/L·h) in association to a signiﬁcant shortening of
the required cultivation time (from 72 to 48 h) and a ﬁnal EPS
concentration of 26 g/L (Fariña et al., 1998). Considering that
typical batch cultures for scleroglucan production were usually
described with a length of around 100 h (McNeil and Harvey,
1993), these latter results would be quite promising. A scheme
depicting the optimized and standardized method for production
and recovery of scleroglucan by S. rolfsii ATCC 201126 is shown
in Figure 4.
Concerning scleroglucan production optimization, our ﬁrst
studies in this ﬁeld were performed by using the one-factor-at-a-
time method, which consists in changing one variable (nutrients,
pH, temperature, etc.) while ﬁxing the others at certain arbitrary
levels (Fariña et al., 1998). This technique was also successfully
applied to other EPSs (Xu et al., 2003). Nevertheless, because
of the great number of factors that are involved in the process,
this method usually implies a large number of experiments, and
thus results very laborious and time consuming, and not always
guarantees the disclosure of optimal conditions (Survase et al.,
2006). Diﬀerent methods have been proposed in the literature
for the empirical modeling and optimization of EPS production
which may behave more eﬃciently and/or accurately.
With reference to scleroglucan from S. rolfsii MTCC 2156,
two main methods were proposed, one consisting in a statistical-
based approach (response surface methodology) and the other
one, in an artiﬁcial intelligence-based approach (artiﬁcial neural
network-genetic algorithm; Desai et al., 2008). Both methods
allowed a signiﬁcant increase in scleroglucan titers (from
7.8 ± 0.54 g/L in non-optimized medium to 16.42 ± 0.68 g/L
and 16.22 ± 0.44 g/L for artiﬁcial neural network-genetic
algorithm and response surface methodology, respectively) with
the requirement of a minimum number of experiments. Both
methods provided a deep knowledge (e.g., interactions between
diﬀerent components) on the scleroglucan production system.
Moreover, artiﬁcial neural network-genetic algorithm allowed
predicting more accurate values of optimal conditions and
optimum titers as compared to response surface methodology.
Fermenter Configuration
Relatively little information is available on the inﬂuence of
fermenter conﬁguration on α- or β-glucan yields in fungi (McNeil
and Harvey, 1993; Gibbs and Seviour, 1996; Wang and McNeil,
1996). Bioreactor architecture is mainly involved in the eﬃcient
homogeneous mixing of the culture, especially promoting heat,
oxygen and other substrates mass transfer to the cells (Rau et al.,
1992; McNeil and Harvey, 1993). STRs are the workhorse in the
fermentation industry, and they are the most utilized at both
research and industrial scale (Lawford and Rousseau, 1989; Kang
et al., 2000).
FIGURE 4 | Flowchart illustrating the main stages during production and downstream processing of scleroglucan from S. rolfsii ATCC 201126 (Fariña
et al., 1998; Viñarta et al., 2013a). Chain starts with production at fermenter scale with MOPT culture medium under the following operative conditions:
400 rpm, 0.5 vvm and 30◦C, in a BioFlo 110 fermenter (New Brunswick Sci.) with an 8 L-working volume. Preliminary EPS recovery; EPS purification;
Final EPS treatments for storage and usage. After biomass separation by centrifugation.
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Two conﬁgurations are the most commonly used for fungal
fermentations: the continuous STR and the ALR, whose
diﬀerent principles of mixing represent a high- and low-
shear regime, respectively (Seviour et al., 1992; Gibbs et al.,
2000; Papagianni, 2004). Even though data are available in the
public domain, it is diﬃcult to separate the complex individual
eﬀects of shear/mixing/mass transfer or DO levels and biomass
morphology on β-glucan production, mainly, because of the
performed experiments were not conceived to diﬀerentiate
between each eﬀect.
A stirrer system that imparts a high shear stress upon
the medium normally uses Rushton turbine impellers, which
pump out the medium radially from the turbine (McNeil and
Harvey, 1993; Wang and McNeil, 1996; Gibbs et al., 2000;
Papagianni, 2004; Fazenda et al., 2008). Radial ﬂow (turbine)
impellers are eﬃcient at achieving oxygen transfer by virtue of
their ability to increase turbulence. Their eﬃciency is, however,
counteracted by the negative eﬀect of this shear intensive system
on the “quality” of the isolated exopolymer. Product quality is
a relative term that can only be properly deﬁned in terms of
the end-use application (Lawford and Rousseau, 1991). As stirrer
speed augments in a high-shear conﬁguration, oxygen and heat
mass transfer rates increase whilst the mixing times decrease
(McNeil and Kristiansen, 1987). Fungal morphology is often
quite diﬀerent from that seen in low-shear systems (Gibbs et al.,
2000; Papagianni, 2004; Fazenda et al., 2008; García-Ochoa and
Gómez, 2009).
In smaller laboratory fermenters, and particularly for
polysaccharide fermentations, wall eﬀects become signiﬁcant. It
is not unusual to see impellers turning at high rpm and stagnant
broth a few inches away. Poor mixing, particularly near the walls,
is worsened by the presence of excessive baﬄing, cooling devices,
pH and dissolved oxygen probes, and sampling lines (Wernau,
1985). These diﬃculties have been frequently observed during
scleroglucan production by S. rolfsii ATCC 201126 (see below,
Figures 5A,B).
The most common conﬁguration to work under low-shear
conditions is the ALR, which uses diﬀerences in hydrostatic
pressure or density in order to achieve a ﬂuid mixing. Air is
injected through a sparger into the bottom of a riser tube,
decreasing the eﬀective density of the medium there. As bubbles
rise to the top, they are released into the headspace; the medium
becomes denser and it then descends to the vessel bottom via a
downcomer or an external loop (McNeil and Harvey, 1993; Gibbs
et al., 2000; Chisti and Jauregui-Haza, 2002; Papagianni, 2004;
García-Ochoa and Gómez, 2009).
On the other hand, although less used, low-shear
conﬁgurations in continuous STRs rely on modiﬁcations of
the stirring systems and the impellers. Available low-shear
impellers include axial ﬂow and helical ribbon stirrers. The
operation in both cases implies the pumping of the ﬂuid from
the top to the bottom of the fermenter at reduced liquid stress
and against the airﬂow (Rau et al., 1992; McNeil and Harvey,
1993). For schizophyllan, a β-glucan similar to scleroglucan, EPS
production reached higher values in fermenters with axial ﬂow
impellers than with helical ribbon stirrers (Rau et al., 1992).
The use of ALRs is being increasingly considered in
fermentation industries instead of the traditional mechanically
agitated bioreactor. Their design is mechanically simpler
than the observed in STRs, and because of the absence of
mechanical stirring, they are also less expensive to operate.
Main advantages include low power inputs, relatively low
shear, simple construction, and no moving mechanical parts,
which additionally reduces contamination risks. Despite this, the
comparatively low shear regime and lower oxygen transfer rates
may represent diﬃculties at the time of cultivating ﬁlamentous
fungi (Barker and Worgan, 1981; Blenk, 1985; Merchuk and
Siegel, 1988; Allen and Robinson, 1989). These diﬃculties can
be satisfactorily solved by the introduction of internal or external
loops (Seviour et al., 2011b).
Higher EPS scleroglucan concentrations could be achieved
with S. glucanicum NRRL 3006 (Wang and McNeil, 1995d) in
a 120-L ALR with an external loop in comparison with the
classical STRs, probably by satisfying a low oxygen demand
when using the ALR fermenter architecture. Similarly, Kang
et al. (2000), investigated scleroglucan production in an ALR
with an internal loop. They found that scleroglucan productivity
obtained in this system was comparable to those achieved in
ALRs with an external loop or in stirred-tank reactors, presenting
the additional advantage of low equipment investment and
operational costs (Kang et al., 2000). Despite the clear economic
advantages that ALRs oﬀer for scleroglucan industrial or lab-
scale production, these systems are not commonly used, perhaps
because the lack of knowledge in this bioreactor conﬁguration of
FIGURE 5 | Scleroglucan production by S. rolfsii ATCC 201126 with alternative C-sources: (A) Sugarcane molasses, (B) Corn starch or, (C) Ground
lemon peel. Aspect of EPS precipitate (D) after settling overnight at 5◦C the corn starch-broth supernatant with an equivalent volume of ethanol 96◦. (A,B)
2 L-working volume fermenter scale. (C) 100 mL-working volume shake-flask scale. Other culture medium components, as in PM20 (Fariña et al., 1998).
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both, process rheology and hydrodynamics (Wang and McNeil,
1996).
In conclusion, the technology of scleroglucan production still
seems to be an aspect deserving further investigation, since the
choice of fermenter design will help to determine the ultimate
economic attractiveness of any proposed industrial process.
Utilization of Alternative or
Non-Conventional Substrates
At present and mainly for economic reasons, most of the
commercialized polysaccharides are derived from plants, with the
exception of xanthan and curdlan gums which are from bacterial
origin (Clementi, 1997; Sutherland, 2008). The introduction of
fungal EPSs like scleroglucan in the market is usually limited
by low yields and high production costs. Therefore, unraveling
these shortcomings may help to expand the scleroglucan market
to relevant areas such as pharmaceuticals, cosmetics, food and
agriculture (Singh et al., 1974; Pretus et al., 1991; McNeil and
Harvey, 1993; Wang and McNeil, 1996). A tactic to reduce
the costs and boost EPS production may involve developing
fermentative processes that strategize the use of cheap and/or
easily available substrates. Scleroglucan production commonly
considers the use of conventional substrates like sucrose or
glucose as C-source (Fariña et al., 1998; Survase et al., 2006;
Schmid, 2008; Schmid et al., 2010), along with small amount
of salts, yeast extract and nitrate as N-source. These latter are
not quite expensive, however, their use might have more impact
on production costs at industrial scale. Therefore, some authors
have highlighted the importance of evaluating the employment
of certain wastes or agro-industrial sub-products as potential
scleroglucan production substrates.
Survase et al. (2007b) reported high scleroglucan production
with S. rolfsii MTCC 2156 by using in culture medium either
sugarcane molasses (∼19 g EPS/L) or coconut water (∼13 g/L).
On the other hand, a reduction in production costs could also
be achieved with S. glucanicum NRRL 3006 in a culture medium
containing a sub-product coming from corn-based ethanol
production [Condensed Corn Soluble (CCS); Fosmer et al., 2010].
Similarly, other researchers found high scleroglucan yields by
growing S. glucanicum NRRL 3006 in culture media based on
starch-derived raw materials (Selbmann et al., 2002a). The use
of alternative substrates may represent an attractive proposal not
only from the economic point of view, but also at environmental
level. It would allow reducing production costs at the same time
of giving added value to non-valuable wastes or sub-products
with scarce commercial value, what entails a revalorization of
these alternative substrates. Additionally, their conversion into
high-added-value bio products (EPS) would also contribute to
the mitigation of the environmental impact generated by their
eventual disposal in nature (Fernandes Silva et al., 2009; Taskin
et al., 2011; Abdul Razack et al., 2013; Muhammadi and Afzal,
2014).
In recent years, with the aim of reducing production costs for
scaling-up and based on the S. rolfsii ATCC 201126 ability to
metabolize diverse C-sources, our group evaluated the possibility
of using diﬀerent available agro-industrial sub-products with
relevance in the region (Valdez, 2013). Under-utilized biomasses
such as vegetable and fruit processing residues constitute a
promising source, being generated in huge amounts every year
and representing an environmental and economic problem of
worldwide concern. Among these residues, peels, seeds and
pulps constitute a 30–50% of input materials contributing with
high organic matter to the environment. These agro-wastes
might then be envisaged as suitable C-sources for revalorization
through the production of high added-value biotechnological
products (“bioreﬁnery” strategy) such as EPSs (Poli et al., 2011).
Simultaneously, this would aid to cope with the depletion of
natural resources and environmental concerns.
Among alternative substrates, the use of sugarcane molasses
and lemon peel have been tested for scleroglucan production by
S. rolfsii ATCC 201126 (Valdez, 2013; Montes de Oca, 2014). The
former one is a liquid by-product of the sugar industry with a
dark brown color, highly viscous and homogeneous appearance,
where the major sugar component is sucrose. Some ions like
Mg2+, Mn2+, Al3+, Fe3+, and Zn2+ may also be present in
variable proportions (Prescott and Dunn, 1987).
Molasses (≡20 g/L reducing sugars) with no pre-treatment
could be used in culture medium which led to proper growth
and scleroglucan production in S. rolfsii ATCC 201126 (Valdez,
2013). Conversely, Roukas and Liakopoulou-Kyriakides (1999)
proposed a pre-treatment of this substrate prior to pullulan
production, due to the presence of heavy metals with inhibitory
eﬀects on microbial growth and EPS-linked enzymatic activities.
In our case, the maximal scleroglucan production at bioreactor
scale with molasses as C-source (5.11 g/L; Figure 5A) was
moderately lower than the one normally achieved in control
medium with 20 g/L sucrose (6.87 g/L). The crude EPS obtained
under these conditions exhibited an undesirable brownish
coloration, likely related to the presence of melanoidins as the
main pigment in sugarcane molasses (Chandra et al., 2008).
However, this pigmentation could be signiﬁcantly reduced once
EPS downstream processing was completed, thus reﬂecting a
higher purity grade.
As the quality and EPS structural features may vary depending
on the C-source, the obtained EPS was evaluated on its purity
degree and rheological characteristics (Castillo et al., 2014). The
EPS coming from molasses medium showed high purity values
(93% w/w total sugars, 9.1% w/w reducing sugars, with minimal
protein contamination). Aqueous solutions containing this EPS
showed non-Newtonian pseudoplastic behavior with better
rheological properties (higher consistency coeﬃcient, K, and
lower ﬂow behavior index, n) as compared to the EPS obtained
from conventional sucrose, at identical EPS concentration.
These results allowed us to conﬁrm the feasibility to produce
high-quality scleroglucan from sugarcane molasses, which may
represent a more economic option, especially for regions where
this sugar industry by-product is abundant (Koller et al., 2012).
That would be valuable at industrial level at the time of facing
large-scale production and taking into account the wide potential
uses of this EPS. Applications may include from the utilization
of the whole culture broth, as for enhanced oil recovery (EOR;
Sandford, 1979; Holzwarth, 1984), to the use of a reﬁned grade
EPS (e.g., for cosmetic, pharmaceutical or medical applications;
Pretus et al., 1991; Falch et al., 2000; Mueller et al., 2000; Coviello
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et al., 2005; Laroche and Michaud, 2007; Viñarta et al., 2007;
Giavasis, 2014).
The use of commercial corn starch (≡20 g/L reducing sugars)
has also been tested as C-source for scleroglucan production by
S. rolfsii ATCC 201126 at bioreactor scale (Valdez, 2013). Under
these conditions, EPS production (7.95 g/L; Figure 5B) exceeded
the obtained values with the same concentration of either sucrose
or molasses as C-source. The obtained EPS was more easy to
precipitate (Figure 5D) and the eﬃciency of the recovery process
thus ascended from the typical ∼30% (28.5% with sucrose and
33.2% with molasses, respectively) to above 50%. Purity analyses
of EPS revealed similarities in total and reducing sugars, and
protein contents as in the EPSs obtained with sucrose ormolasses.
Rheological properties, however, for an equal EPS concentration,
indicated a lower K value in comparison to the molasses-EPS
but higher than the traditional sucrose-EPS. In this sense, our
results have oriented us to the study on the use of low-cost
amylaceous materials or residues, as potato washing wastewater.
The alternative use of cheese whey (Fernandes Silva et al., 2009)
and olive mill wastes (Dermeche et al., 2013) is also being
considered.
Another C-source more recently tested with S. rolfsii ATCC
201126 was the ground- and acid-treated lemon peel obtained
from a local citrus-processing factory (Montes de Oca, 2014). The
use of this substrate (∼=15 g/L reducing sugars; Figure 5C) led
to interesting EPS production values (∼13 g/L), even surpassing
the ﬁnal EPS concentrations (5–8 g/L) in sucrose-, molasses-,
or corn starch-containing media (Valdez, 2013). However, the
maximal EPS concentration in pre-treated citrus-peel-containing
media could just be achieved at 7 days of cultivation instead of
the 2–3 days required for culture media with sucrose, molasses
or corn starch as C-sources. An additional aspect to consider
is that pectin (released from citrus peel to culture broth)
may co-precipitate along with EPS when alcohol is added for
the recovery process. This hitch could be partially solved by
previously treating the samples (48 h at 40◦C) with commercial
pectinase (Montes de Oca, 2014). The practicability of using
citrus peel for EPS production should then be carefully weighed
taking into account that factors such as the pre-treatment of
raw material, the longer cultivation time and the remaining
pectin interference may deleteriously inﬂuence the production
process costs. On the other hand, despite the cited limitations
for EPS production, the ﬁnding of an appropriate fungal growth
along with the secretion of a wide variety of enzymes with this
substrate would allow to suggest these cultivation conditions
for the production of other biotechnologically relevant products,
such as hydrolytic and ligninolytic enzymes (Montes de Oca,
2014).
As a ﬁnal point, it is already described in the literature
that S. rolfsii and S. glucanicum behave as phytopathogens
with the natural ability to produce a wide enzymatic spectrum
including cellulases, phosphatases, arabinases, exogalacturonases,
polygalaturonases, galactosidases, and exomannanases (Survase
et al., 2007b). It can be therefore expected that some plant
residues such as sugarcane bagasse (Koller et al., 2012), solid
olive-mill by-product called “alperujo” or olive mill wastewater
(“alpechin”; Dermeche et al., 2013) may also be evaluated
as potential unconventional raw materials for the low-cost
scleroglucan production within an eco-sustainable framework.
Nevertheless, in spite of all the work performed up to date
and their prospects, scleroglucan production at industrial scale
still remains limited to glucose or sucrose, which makes the
ﬁnding of alternative substrates as well as the reduction of costs a
continuing challenge to keep working on.
DOWNSTREAM PROCESSING
As relevant as improved cultivation conditions are for achieving
high polymer yields, the downstream processing also represents
a crucial step in order to ensure a high recovery yield of
a reﬁned-grade polysaccharide. This stage may aﬀect critical
macromolecular features such as polymer MW, DP, DB, purity
and composition, and also constitutes a signiﬁcant part of
the total production costs (Wasser, 2002; Wang et al., 2010;
Viñarta et al., 2013a,b). This processing stage optimization
becomes imperative and, depending on the desired purity or
the intended use (which usually requires given physico-chemical
properties), diﬀerent extraction and puriﬁcation techniques
should be developed.
In the case of extracellular slimy polysaccharides, this
process generally involves the sterilization or pasteurization
of the fermentation broth in order to kill microbial cells,
inactivate undesirable enzymes (e.g., glucanases) and facilitate
EPS detachment from cells. The subsequent removal of biomass
is frequently carried out by ﬁltration or centrifugation. The
polysaccharide in the cell-free ﬁltrate or centrifugate is then
precipitated with alcohol, followed by further puriﬁcation steps
(if required) such as ultraﬁltration, gel permeation/ion-exchange
chromatography, or diaﬁltration. The end product is ﬁnally
obtained after drying with either air/inert gas under vacuum,
spray drying, or lyophilization, plus a ﬁnal milling to the desired
mesh size (Giavasis, 2013).
Referring to the S. rolfsii ATCC 201126 scleroglucan
downstream processing, diﬀerent strategies were evaluated in
order to ﬁnally establish an optimized puriﬁcation protocol.
That led to an industrially acceptable recovery of EPS with high
purity grade (∼98%; Fariña et al., 2001; Viñarta et al., 2013b).
This protocol commonly involves a step of homogenization to
facilitate the EPS release from mycelium and to weaken the
intermolecular polysaccharide association, so that it is completely
dispersible in water. This is followed by a threefold dilution of
culture broth with distilled water, which otherwise is extremely
viscous and diﬃcult to process, and a ﬁnal neutralization with
NaOH. Thereafter, the diluted/neutralized broth is heated (80◦C
for 30 min) to inactivate eventually produced glucan-degrading
enzymes and to enhance glucan solubilization in water, and
ﬁnally centrifuged (27500× g, 15◦C, 20min). The EPS from clear
supernatant is then precipitated by adding an equivalent volume
of an organic solvent, commonly a lower alcohol.
Generally speaking, when a polysaccharide is present,
fungal mycelia are easier to remove from diluted broths; but
the additional cost of re-concentration normally imposes an
economic drawback (Wernau, 1985). The possibility to achieve
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FIGURE 6 | Appearance of EPSs produced by S. rolfsii ATCC 201126 at
fermenter scale in MOPT culture medium and subsequently
downstream processed. EPSi corresponds to scleroglucan precipitated
with isopropanol after 1 (A), 2 (B), or 3 (C) re-dissolution/re-precipitation steps.
EPSp illustrates the EPS precipitated with PEG. EPS I and EPS II correspond
to ethanol-precipitated scleroglucans after 48 or 72 h of cultivation (Fariña
et al., 1998; Viñarta et al., 2013b).
a high recovery of pure scleroglucan from diluted supernatants
of S. rolfsii ATCC 201126, from ∼30% (with sucrose or molasses
media) up to 50% (with corn starch medium), attenuates this
disadvantage. Concerning the precipitation step for EPS recovery,
diﬀerent alcohols (ethanol 96◦, isopropanol, and PEG) were
tested (Johal, 1991; Fariña, 1997; Fariña et al., 2001; Viñarta et al.,
2013b). Among them, we found that ethanol 96◦ and isopropanol
allowed obtaining the highest recovery, high purity degree, ﬁnest
appearance, optimal water solubility and remarkable rheological
properties of EPS (Figure 6). In addition to the ﬁrst precipitation
step at the end of centrifugation, the inclusion of a three-step re-
precipitation/re-dissolution cycle (Figure 4) with either ethanol
or isopropanol, was the best methodology to achieve a reﬁned-
grade scleroglucan, suitable for example for biomedical testing
(Fariña et al., 2001; Viñarta et al., 2013b).
OPERATIONAL STRATEGIES
As scleroglucan represents a growth-associated metabolite,
it has been early recognized that those conditions favoring
growth will also do so on EPS production. However, it
was noted that some required conditions that seem to
promote polysaccharide production do not always imply the
stimulation of growth but the opposite. This gave place to
bi-staged processes, where optimal conditions for biomass
production are supplied during the ﬁrst stage and then, once
a critical biomass has been produced, the conditions are
changed in order to stimulate EPS production (Sutherland,
1982).
The commonly selected method for EPS production is
the batch process, where the producing microorganism is
inoculated into the culture medium which contains all the
required nutrients. Under these conditions, growth and
EPS production take place until the exhaustion of a given
critical substrate (which usually turns limiting). On the other
hand, the continuous culture strategy, which consists in the
uninterrupted addition of fresh culture medium whilst spent
broth (containing part of the biomass and the product of
interest) is simultaneously harvested, is not frequently used for
EPS production (Rosalam and England, 2006). Nevertheless,
this latter methodology has been eventually employed to
study biochemical and physiological aspects related to some
polysaccharide-production processes (Sutherland, 1982). In the
case of scleroglucan, an alternative continuous culture process
at lab and industrial-scale has been patented years ago (Maier,
2004).
Unfortunately, in contrast to batch-wise cultivation,
continuous culture resulted not feasible under non-aseptic
conditions, being less eﬀective with regard to yield and product
quality, as compared to batch cultures (Schilling, 2000). It may
also be worthwhile to highlight that for some microorganisms
such as the xanthan-producer Xanthomonas campestris, the
continuous culture strategy might lead to the undesirable
selection of poorly EPS-producing strains (Sandford, 1979).
In order to improve scleroglucan production by S. glucanicum
NRRL 3006, some researchers developed a bi-staged process.
During the ﬁrst phase of cultivation, pH was controlled at 3.5
with the aim of promoting optimal growth, and thereafter pH was
raised up to 4.5 to favor polysaccharide biosynthesis. The second
stage allowed achieving a 10% reduction of by-product (oxalic
acid) formation, simultaneously with an increased scleroglucan
concentration. This factmay reﬂect that pH levels (i.e., 4.5) higher
than those for optimal growth prompt the carbon ﬂux toward
biopolymer synthesis (Wang and McNeil, 1995c). In a similar
way, the chosen process temperature is often a compromise
between the optimal temperature for growth and the one for
EPS production. A bi-staged process of temperature could also
be adopted for the improvement of polysaccharide synthesis
at a second stage (Wu et al., 2010). The use of dual-stage
production processes have been also successfully applied to other
microbial polysaccharides in order to achieve diﬀerent optimal
conditions, either for growth or biopolymer synthesis (Zheng
et al., 2013).
Although batch cultures are usually adopted on an industrial
scale, a fed-batch process with a stepwise addition of the C-source
(and further nutrients) may often improve the ﬁnal product
concentration, thus eliminating any eventual substrate inhibition.
The feeding of concentrated medium to the culture is commonly
performed at a rate that prevents the carbon source from
reaching the threshold value for catabolite repression (Spohr
et al., 1998). In the case of scleroglucan from S. glucanicum
NRRL 3006, this methodology has been reported to avoid the
inhibitory eﬀects of high (≥45 g/L) initial sucrose concentrations
(Taurhesia and McNeil, 1994b). Supplemented batch cultures
(at around 72 h) with additional sucrose after the initial
growth phase overcame these diﬃculties while improving EPS
production and its yield on C-source. The feeding strategy has
also been reported for polysaccharides such as curdlan (Lee
et al., 1997), gellan (Wang et al., 2006), scleroglucan (Survase
et al., 2007a; Fosmer et al., 2010), ganoderan (Tang and Zhong,
2002), and Saccharomyces cerevisiae glucan (Kim and Yun,
2006).
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METABOLIC AND GENETIC
ENGINEERING AS A TOOL FOR
INCREASING EPS PRODUCTION
A better understanding of the EPS biosynthesis regulation will
be crucial to face a rational and not empirical optimization
of polysaccharide production. Acquiring this information
might be challenging, but essential to produce tailor-
made EPSs with enhanced bioactivity and more attractive
physicochemical properties (Angelova and Hunkeler, 1999).
The advancement in practical tools for genetic manipulation
of fungi would be the main ally for elucidating EPS
biosynthetic pathways and their regulation (Seviour et al.,
2011a).
At the moment, much is known about the physicochemical
properties of scleroglucan and its applications. Conversely,
up to a few years ago, there was a lack of information
regarding its biosynthetic pathway and regulation, at both
genetic and enzymatic levels. First discernments in this
ﬁeld were recently published by Schmid et al. (2010)
who established the ﬁrst sequence database for S. rolfsii
ATCC 15205. These authors compared the gene expression
and transcriptomes of S. rolfsii under conditions of
either maximum or minimum scleroglucan production.
Obtained data allowed them to predict the pathways
for scleroglucan and oxalate synthesis and degradation,
and led to the knowledge that metabolic pathways for
scleroglucan and oxalate synthesis were not coupled to
each other, as it was believed, but oxalate synthesis may
be rather linked to biomass formation (Schmid et al.,
2011).
The same group of researchers could also identify important
unigenes putatively involved in determining scleroglucan yields,
and found that almost all the genes supposed to be involved
in scleroglucan synthesis, glycolysis, TCA, and glyoxylate
cycles were not diﬀerentially transcribed under high- or
low scleroglucan producing conditions. Their results further
suggested that the regulation of polymer synthesis would be
rather linked to mechanisms ensuring fungal survival under
anoxic and other stress conditions (Schmid et al., 2011).
The complete genome sequencing of scleroglucan-producing
strains, along with metabolomics and proteomics inputs, would
provide a real boost toward the optimization of scleroglucan
production.
CONCLUDING REMARKS
With the advent of modern biotechnology, a new perspective
for the use of fungi as generators of innovative products was
completely opened up. Scleroglucan biopolymer belongs to these
original products of fungal origin, and due to its versatility
and unique properties it may ﬁnd its way into numerous
industries, such as oil, cosmetics, food, and pharmaceuticals.
Microbial production of scleroglucan, both at lab and industrial
scale, remains as one of the most multifaceted processes
currently known. The optimization of scleroglucan production
as well as solving its related obstacles will ensure the economic
success of this development and its competitiveness. That will
involve integrating the inputs from multiple disciplines such
as microbiology, biochemical engineering, process engineering,
statistics and genetics.
In this chapter we have reviewed much of the knowledge
on scleroglucan production to date, particularly regarding
the process design and optimization, and by examining both
the available literature and our experience. There are still
several hitches mainly regarding to the bioreactor design and
process development for large-scale scleroglucan production,
which are expected to be solved during the following
years. Additionally, a deeper insight into the scleroglucan
biosynthesis and its regulatory networks will also be crucial
for the process optimization. This information, together with
genetic engineering and transformation techniques, may allow
modifying the expression of scleroglucan-biosynthesis related
genes in order to divert more carbon ﬂux toward polysaccharide
production.
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